117 related articles for article (PubMed ID: 6821635)
1. Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification.
Leonard RC; Cuzick J; MacLennan IC; Vanhegan RI; Mackie PH; McCormick CV
Br J Cancer; 1983 Jan; 47(1):91-102. PubMed ID: 6821635
[TBL] [Abstract][Full Text] [Related]
2. Outline of a prospective multicentric study on the clinical significance of the Kiel classification of non-Hodgkin's lymphomas.
Brittinger G
Recent Results Cancer Res; 1978; 65():197-202. PubMed ID: 746247
[TBL] [Abstract][Full Text] [Related]
3. A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma.
Steward WP; Todd ID; Harris M; Jones JM; Blackledge G; Wagstaff J; Anderson H; Wilkinson PM; Crowther D
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):881-9. PubMed ID: 6547675
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.
Rasmuson T; Björk GR
Acta Oncol; 1995; 34(1):61-7. PubMed ID: 7865238
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in non-Hodgkin's lymphomas.
Gobbi PG; Ricevuti G; Balduini C; Cavalli C; Gendarini A; Bonfichi M; Rizzo SC; Ascari E
Acta Haematol; 1985; 74(2):86-91. PubMed ID: 3937421
[TBL] [Abstract][Full Text] [Related]
6. [A clinical study of the non-Hodgkin's lymphomas according to the Kiel classification (author's transl)].
Stacher A; Heinz R; Waldner R
Arch Geschwulstforsch; 1979; 49(8):715-30. PubMed ID: 120730
[TBL] [Abstract][Full Text] [Related]
7. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
Stacher A; Heinz R; Waldner R; Böhnel J
Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
[TBL] [Abstract][Full Text] [Related]
8. Morphologic classification of non-Hodgkin's lymphoma. I. Retrospective analysis using the Kiel classification.
Glimelius B; Sundström C
Acta Radiol Oncol; 1982; 21(5):289-97. PubMed ID: 6297247
[TBL] [Abstract][Full Text] [Related]
9. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
10. [Experience with results of treatment of non-Hodgkin's lymphoma].
Gurzó M; Dobos K; Bérczi M; Varga G; Kelényi G
Orv Hetil; 1992 May; 133(18):1091-7. PubMed ID: 1579348
[TBL] [Abstract][Full Text] [Related]
11. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
Fasola G; Fanin R; Gherlinzoni F; Galieni P; Taruscio D; Frezza G; Mazza P; Pileri S; Baccarani M
Acta Haematol; 1984; 72(4):231-8. PubMed ID: 6438991
[TBL] [Abstract][Full Text] [Related]
12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of malignant lymphomas].
Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
16. [Primitive digestive localizations of malignant non-Hodgkin's lymphoma. Prognostic factors of locally advanced disease: stage II. Report of 67 cases].
Rougier P; Azab M; Henry-Amar M; Bognel C; Lasser P; Cosset JM; Caillou B; Theodore C; Droz JP; Crespon B
Gastroenterol Clin Biol; 1990; 14(8-9):626-34. PubMed ID: 2227234
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic parameters in patients with advanced non-Hodgkin's lymphoma].
Terblanche AP; Falkson G
S Afr Med J; 1986 Mar; 69(6):358-63. PubMed ID: 3961618
[TBL] [Abstract][Full Text] [Related]
18. Extranodal non-Hodgkin's lymphoma of the oral tissues. An analysis of 20 cases.
Slootweg PJ; Wittkampf AR; Kluin PM; de Wilde PC; van Unnik JA
J Maxillofac Surg; 1985 Apr; 13(2):85-92. PubMed ID: 3858400
[TBL] [Abstract][Full Text] [Related]
19. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
Akerman M; Brandt L; Johnson A; Olsson H
Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
